A
|
| ADS |
Analytical Decision Support |
| AIG |
Anthrax Immune Globulin |
| AMCG |
Office of Acquisition Management, Contracts, & Grants |
| AMIC |
Animal Model Interagency Committee |
| Arenavirus |
The Arenaviridae are a family of viruses whose members are generally associated with rodent-transmitted diseases in humans. Each virus usually is associated with a particular rodent host species in which it is maintained. |
| Animal Efficacy Rule |
The FDA Animal Efficacy Rule (also known as Animal Rule) applies to development/testing of drugs / biologicals to reduce or prevent serious/life-threatening conditions caused by exposure to lethal /permanently disabling toxic agent (chemical, biological, radiological, or nuclear substances), where human efficacy trials are not feasible or ethical |
| ARS |
Acute Radiation Syndrome; also known as radiation poisoning, radiation sickness or radiation toxicity, is a collection of health effects which present within 24 hours of exposure to high amounts of ionizing radiation. |
| ASPR |
Assistant Secretary for Preparedness and Response |
B
|
| BAA |
Broad Agency Announcements |
| BARDA |
Biomedical Advanced Research and Development Authority |
| BPN |
Business Partner Network |
| BSA |
Broad Spectrum Antimicrobials |
C
|
| CAP |
Concept Acceleration Program |
| CBMS |
Chemical Biological Medical Systems |
| CBRN |
Chemical, Biological, Radiological and Nuclear Threats |
| CDC |
Center for Desease Control |
| CDER |
Center for Drug Evaluation and Research |
| CFR |
Code of Federal Regulations |
| CIADM |
Centers for Innovation in Advanced Development and Manufacturing |
| CLIA |
Clinical Laboratory Improvement Amendment |
| CSN |
Clinical Studies Network |
D
|
| DARPA |
Defense Advanced Research Projects Agency |
| DCEG |
Division of Cancer Epidemiology and Genetics |
| DCS |
Clinical Studies group |
| DHS |
Department of Homeland Security |
| DoD |
Department of Defense |
| DSMB |
Data Safety Monitoring Board |
| DTRA |
Defense Threat Reduction Agency |
E
|
| EID |
Emerging Infectious Diseases |
| EMS |
Emergency Medical Services |
| EUA |
Emergency Use Authorization |
F
|
| FAR |
Federal Acquisition Regulations |
| FD&C |
Federal Food, Drug and Cosmetic Act |
| FDA |
Food and Drug Administration |
| FedBizOpps |
Federal Business Opportunities |
| FFMN |
Fill Finish Manufacturing Network |
G
|
| GI |
Gastrointestinal |
| GPE |
Government Point-of-Entry |
Back to top
H
|
| HGS |
Human Genome Sciences |
| HHS |
U.S. Department of Health and Human Services |
| HHSAR |
Department of Health and Human Services Acquisition Regulation |
I
|
| IEDB |
Immune Epitope Database |
| IND |
Investigational New Drug |
J
|
| JOFOC |
Justification for Other than Full and Open Competition |
M
|
| MCM |
Medical Countermeasures |
| MCMi |
Medical Countermeasures initiative |
| MMWR |
Morbidity and Mortality Weekly Report |
N
|
| NARA |
National Archives and Records Administration |
| NBLs |
National Biocontainment Laboratories |
| NCI |
National Cancer Institute |
| NHLBI |
National Heart, Lung and Blood Institute |
| NIAID |
National Institute of Allergy and Infectious Diseases |
| NIH |
National Institutes of Health |
| NINDS |
National Institute of Neurological Disorders and Stroke |
| NSABB |
National Science Advisory Board for BioSecurity |
Back to top
O
|
| OEM |
Office of Emergency Management |
| OMB |
Office of Management and Budget |
| OPP |
Office of Policy and Planning |
P
|
| PAHPA |
The Pandemic and All Hazards Preparedness Act |
| PBS |
Project BioShield |
| PDTs |
Product Development Tools |
| PEP |
Post-Event Prophylactic |
| PHCM |
Public Health Consequence Modeling |
| PHEMCE |
Public Health Emergency Medical Countermeasures Enterprise |
| PHS |
Public Health Service |
R
|
| RBLs |
Regional Biocontainment Laboratories |
| RCE |
Regional Centers of Excellence |
| REB |
Radiation Epidemiology Branch |
| RFP |
Request for Proposal |
| RQA |
Division of Regulatory and Quality Affairs |
| RSV |
Respiratory Syncytial Virus |
| RTOR |
Request for Task Order Response |
S
|
| SAE |
Serious Adverse Event |
| SIP |
Strategy and Implementation Plan |
| SNS |
Strategic National Stockpile |
| SST |
Strategic Science and Technology |
T
|
| TICs |
Toxic Industrial Chemicals |
| TIMs |
Toxic Industrial Materials |
| TMTI |
Transformational Medical Technologies Initiative |
| TRA |
Terrorism Risk Assessment |
| TRLs |
Technology Readiness Levels |
